GPP
HZNP

Great Point Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Great Point Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500,000
Closed -$3.81M – 40
2013
Q4 		$3.81M Buy
500,000
+400,000
+400% +$2.16M 2.69% 19
2013
Q3 		$335K Buy
+100,000
New +$264K 0.23% 28

Other funds holding HZNP

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Great Point Partners's HZNP Position: Q1 2014 in Review

Great Point Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2014, closing a stake of 500,000 shares — an estimated $3.81M sold.

Great Point Partners first reported a position in HZNP in Q3 2013 and held it in 2 quarters. The position peaked at $3.81M in Q4 2013. 118 funds tracked by Wall St. Rank hold HZNP as of Q1 2014.

  • Great Point Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2014 after selling out during the quarter.
  • Great Point Partners sold 500,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2014, an estimated $3.81M.
  • Great Point Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 2 quarters.
  • Great Point Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.81M in Q4 2013.
  • 118 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2014.

Based on Great Point Partners's 13F filing for Q1 2014, filed 15 May 2014.